Introduction
Methylprednisolone (MPS) plays an irreplaceable role in the treatment of various diseases, including rheumatoid arthritis, systemic lupus erythematous, and acute respiratory distress syndrome (ARDS). However, MPS-induced osteonecrosis of the femoral head (ONFH) is an irreversible and devastating injury. 1 The only treatment option is hip replacement. 2 Thus, there is an urgent need to reduce the risk of ONFH during MPS treatment.
Many studies focus on the risk factors for MPS-induced ONFH. Among them, oxidative stress disorders are a vital concern. 3, 4 Many antioxidants have proven to be effective 
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Deng et al in therapy for steroid-induced osteonecrosis in rat models. 5, 6 It is reported that selenium (Se), an essential micronutrient in humans and animals with a wide range of biologic functions, 7 could suppress oxidative stress and serves as a reactive oxygen species (ROS) scavenger. [8] [9] [10] [11] In some cases, a deficiency of Se could induce oxidative stress and endoplasmic reticulum stress. 12, 13 Due to a narrow margin between beneficial and toxic effects, Se is not safe to use in clinical treatment. 14, 15 By using nanotechnology, Se particles are modified to develop Se@SiO 2 nanocomposites. Accumulating evidence shows that Se@SiO 2 nanocomposites act as antioxidants with reduced toxicity. 16, 17 Thus, we speculated that Se@SiO 2 nanocomposites might serve as a cytoprotectant in MPS-induced ONFH due to their ability to reduce ROS production.
In this study, we investigated whether Se@SiO 2 influenced the therapeutic ability of MPS as well as the femoral head necrosis induced by MPS in rat models. The possible mechanisms underlying the effect of Se@SiO 2 on MPSinduced femoral head necrosis were also explored.
Materials and methods synthesis and characterization of porous se@siO 2 nanocomposites
The detailed synthesis procedures of porous Se@SiO 2 nanocomposites were performed according to the methods reported in our previous study. 18 Briefly, Cu 2-x Se nanocrystals were first prepared and mixed with n-hexane, n-hexanol, Triton X-100, deionized water, and tetraethyl orthosilicate.
[Cu(NH 3 ) 4 ] 2+ was developed by the addition of ammonium hydroxide to the mixture. Oxygen was used to oxidize Se 2− to develop Se quantum dots. The silica coated the Se quantum dots by orthosilicate hydrolysis in an alkaline environment, forming solid Se@SiO 2 nanocomposites. Then, the solid Se@SiO 2 nanocomposites were coated with PVP and etched in hot water to construct porous structures. Se@SiO 2 nanocomposites were characterized by means of a D/max-2550 PC X-ray diffractometer (XRD, Cu-Kα radiation; Rigaku; Tokyo, Japan) and transmission electronic microscopy (JEM-2100F). The cumulative release kinetics of Se from the porous Se@SiO 2 nanocomposites in PBS at 37°C with different pH values (pH 7.4 and pH 5.0) were consistent with those reported in our previous study. 18 
cell lines and animals
The cell line RLE-6TN (rat lung epithelial-T-antigen negative) was purchased from American Type Culture Collection. Cartilage cells were derived from Sprague Dawley (SD) rats. The primary culture of the cartilage cells was performed according to the methods described in a previous study. 19 Briefly, adult SD rats were sacrificed and the head of the femur was exposed under aseptic conditions. The total articular cartilage was isolated and cut into pieces (a volume of ~1 mm 3 ). After digestion with 0.2% collagenase type II and filtration with a cell strainer, the cartilage cells were collected and seeded on tissue culture dishes. All the cells were authenticated twice by morphologic and isoenzyme analyses during the study period. Cell lines were routinely checked for contamination by mycoplasma using Hoechst staining and consistently found to be negative. The cells were cultured with DMEM/F-12 with 10% fetal bovine serum in a 37°C, 5% CO 2 environment. The medium was changed every 2-3 days. The cartilage cells were identified by immunofluorescence staining with collagenase type II and aggrecan (all from Santa Cruz Biotechnology Inc., Dallas, TX, USA).
Eight-week-old female SD rats were purchased from the Experimental Animal Center of Shanghai Jiao Tong University. The rats were bred and maintained under a 12/12-hour light-dark cycle with free access to food and water. The temperature was maintained at 18°C-25°C, and the relative humidity was set to 40%-60%. Rats were housed for a week before the experiments began.
In vitro safety of se@siO 2 
nanocomposites
The in vitro safety of Se@SiO 2 nanocomposites was determined by the inhibitory effect of Se@SiO 2 nanocomposites on cell proliferation. RLE-6TN cells and cartilage cells were seeded at a density of 6×10 3 cells per well in a flat-bottomed 96-well plate in a humidified 37°C and 5% CO 2 atmosphere. The next day, the cells were incubated with an increasing concentration of Se@SiO 2 (ranging from 0 to 180 μg/mL). The medium was replaced every 2 or 3 days. Five days later, the cell proliferation was determined by a Cell Counting Kit-8/WST-8 (Dojindo; Kumamoto, Japan).
a rat model of arDs
The SD rats (n=24) were randomly divided into four groups: control group, Se@SiO 2 group, MPS group, and MPS+ Se@SiO 2 group. All the rats were treated with 4 mg/kg lipopolysaccharide (LPS). Half an hour later, the MPS group was intramuscularly administered 30 mg/kg MPS and the Se@SiO 2 group was intraperitoneally injected with 1 mg/kg Se@SiO 2 . The MPS+Se@SiO 2 group received an intramuscular injection of 30 mg/kg MPS and an intraperitoneal injection of 1 mg/kg Se@SiO 2 . Six hours later, the rats were sacrificed by an intraperitoneal administration of 1% sodium pentobarbital (40 mg/kg). The anterior lobe and the middle lobe of the right lung were excised to determine the wet-to-dry weight ratio. The other lobes of the right lung were cryopreserved 
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Porous se@siO 2 nanocomposites prevent MPs-induced ONFh in liquid nitrogen for further study. Tissues from the left lung lobe, femoral head, heart, liver, spleen, and kidney were kept in neutral formalin solution and embedded in paraffin for morphologic examination. The animal experiments were approved by the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University. All the animals were treated in accordance with the guidelines of the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University.
a rat model of femoral head osteonecrosis
Male SD rats (n=18; 6 rats in each group) were randomly divided into a blank group (blank), a vehicle group (vehicle), and a porous Se@SiO 2 nanocomposite group (NP). The SD rats from the vehicle and NP groups were intravenously injected with 10 μg/kg LPS. After 24 h, these SD rats received three injections of MPS (20 mg/kg) intramuscularly every day. The NP group was also injected intraperitoneally with porous Se@SiO 2 nanocomposites (1 mg/kg) per day. The blank group received saline injections and was housed under identical conditions. To prevent infection, each rat was administered 100,000 U of penicillin intramuscularly. The rats in all the groups were sacrificed 8 weeks after the first MPS injection. The femoral heads of SD rats were harvested. The left femoral heads were preserved in a −70°C cryogenic freezer immediately after sacrifice, and the proteins were isolated for Western blot analysis. The right femoral heads were collected and immediately fixed with 10% formalin (0.1 M phosphate buffer, pH 7.4) at 4°C for 24 h. Then, the samples were used for a micro-computed tomography (Micro-CT) scan and histologic analysis following previous protocols. 20 
glutathione (gsh) and superoxide dismutase (sOD) in lung tissues
Rat lung tissues or cartilages from different groups were lysed in RIPA lysis buffer (Beyotime, Shanghai, China). After centrifuge for 15 min in the speed of 2500 rpm, the levels of glutathione (GSH) and superoxide dismutase (SOD) were detected with reduced glutathione assay kit (Spectrophotometric method) and superoxide dismutase assay kit (WST-1 method), respectively following the instructions provided by manufacturer.
Wet-to-dry weight ratio of the lung tissue
The anterior lobe and the middle lobe of the right lung were excised. The immediate weight was the wet weight. Then, the lungs were heated at 70°C for 2 days. Once the weight was found to be constant, it was measured and recorded as the dry weight. The wet-to-dry weight ratio was calculated by dividing the wet weight by the dry weight.
Western blot
Rat lung tissues or cartilages from different groups were preserved in a −70°C cryogenic freezer immediately after sacrifice, and the proteins were isolated for Western blot analysis. The concentrations of proteins were detected by a BCA protein assay kit (Beyotime). The protein samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Then, the proteins were transferred to polyvinylidene difluoride membranes and immunoblotted with the indicated primary antibody. GAPDH served as a loading control. The primary antibodies were all purchased from Cell Signaling Technology (Boston, MA, USA). After washing three times with TBST, the membranes were incubated with a horseradish peroxidase-conjugated secondary antibody (all from Cell Signaling Technology) for 1 h at room temperature. The proteins were visualized using enhanced chemiluminescence reagents (Plus-ECL; PerkinElmer Inc., Waltham, MA, USA).
histologic analysis
Tissues of rats from different groups were fixed in a neutral formalin solution and were processed for paraffin sectioning. Sections of ~5 μm thickness were stained with H&E or collagen type II. The sections were observed under a light microscope (Leica DM5500 B; Leica Microsystems, Wetzlar, Germany).
Micro-cT procedure
A Micro-CT (GE Healthcare Biosciences, Piscataway, NJ, USA) was used to detect changes in the excised femoral head samples.
statistical analysis
All the values are presented as the mean ± standard error of mean (n=6). Significant differences between groups were determined with GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA, USA) using Student's unpaired t-test. Differences were considered significant at P,0.05.
Results

characterization of porous se@siO 2 nanocomposites
We used the XRD pattern to assess the phase structure of the solid Se@SiO 2 nanocomposites. Many well-defined characteristic peaks in solid Se@SiO 2 nanocomposites showed the hexagonal phase, referenced by the standard Se phase (JCPDS card no 65-1876; Figure 1A 
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The morphology and size of the Se@SiO 2 nanocomposites were determined by transmission electronic microscope. Figure 1B and C shows solid Se@SiO 2 nanocomposites and Figure 1D shows porous Se@SiO 2 nanocomposites. Their diameter was ~55 nm, and there were many small quantum dots interspersed from the center to the surface ( Figure 1B) . The small quantum dots were irregular, and their size was ,5 nm ( Figure 1B and  C) . In addition, the in vitro stability of Se@SiO 2 nanocomposites and the slow release of Se quantum dots from porous Se@SiO 2 nanocomposites were confirmed in our previous study.
The Cell Counting Kit-8 assay was used to determine the cytotoxicity of the Se@SiO 2 nanocomposites on RLE-6TN cells and cartilage cells. The cartilage cells were identified by immunofluorescence staining with collagenase type II and aggrecan ( Figure 1E and F) . The cells were incubated with an increasing concentration of Se@SiO 2 nanocomposites, ranging from 0 to 180 μg/mL ( Figure 1G and H). Compared with the negative control group, the cell viabilities of RLE-6TN cells treated with Se@SiO 2 nanocomposites did not decrease significantly until the concentration of Se@SiO 2 nanocomposites reached 180 μg/mL ( Figure 1G ). In the cartilage cells, no significant difference was observed in the cell viabilities among all the groups with Se@SiO 2 nanocomposite treatment ( Figure 1H ).
Porous se@siO 2 nanocomposites do not impair the therapeutic efficacy of MPS in a rat model of arDs
As shown in Figure 2 , both Se@SiO 2 and MPS induced SOD and GSH-PX, compared with the control group. The levels of SOD and GSH-PX in the MPS plus Se@SiO 2 group were similar to those in the MPS group (Figure 2A and B) . The wet-to-dry weight ratio was significantly decreased in the MPS group compared with the Se@SiO 2 group, whereas the wet-to-dry weight ratio in the MPS plus Se@ SiO 2 group was comparable to that in the MPS group ( Figure 2C ). Western blot was also used to determine the inflammation factors including interleukin (IL)-1β and tumor necrosis factor-alpha (TNF-α) in the control group, Se@ SiO 2 group, MPS group, and MPS+Se@SiO 2 group. The results showed that compared with the control group, Se@ SiO 2 did not significantly decrease the levels of IL-1β and TNF-α ( Figure 2D-F) . However, MPS dramatically reduced the IL-1β level and TNF-α level ( Figure 2D-F) . The addition of Se@SiO 2 to MPS did not increase or decrease the levels of IL-1β and TNF-α in the MPS group ( Figure 2D-F) . Thus, Se@SiO 2 nanocomposites did not influence the therapeutic efficacy of MPS.
We also used histologic analysis to evaluate the damage in the structure of the lung tissues in the rat model of ARDS. We observed alveolar hemorrhage, edema, and inflammatory cell infiltration (Figure 3) . MPS markedly alleviated the lung damage, whereas Se@SiO 2 did not alter the effect of MPS on the injured lung tissues (Figure 3) .
se@siO 2 nanocomposites reduce MPsinduced osteonecrosis in femoral head
A Micro-CT scan was used to determine the therapeutic effect of Se@SiO 2 nanocomposites on osteonecrosis. The results showed that compared with normal bones, MPS induced osteonecrosis ( Figure 4) . Importantly, although Se@SiO 2 nanocomposites did not completely cure osteonecrosis, the necrotic area in the osteonecrotic bones from MPS-treated rats was significantly reduced by Se@SiO 2 nanocomposite therapy ( Figure 4 ).
se@siO 2 nanocomposites protect the cartilage of femoral head from MPsinduced injury
Western blot was also used to determine the levels of IL-1β, collagen II, and aggrecan in the control and Se@SiO 2 groups. IL-1β served as the damage index in the cartilage that objectively evaluates the necrosis situation ( Figure 5 ). Collagen II and aggrecan were properly constructed and functional proteins in the cartilage ( Figure 5 ). Changes in the levels of IL-1β, collagen II, and aggrecan reflected the injuries to the cartilage of the femoral head ( Figure 5) . The results showed that compared with the control MPS group, Se@SiO 2 significantly reduced the IL-1β level induced by MPS ( Figure 5 ). Se@SiO 2 increased collagen II and aggrecan dramatically in the MPS-treated group ( Figure 5 ).
In vivo assessment of safety of se@siO 2 nanocomposites H&E staining and collagen II staining were used for the structural observation of the femur head. MPS induced serious destruction of the femur head. As shown in Figure 6 , compared with the control MPS-induced group, the porous Se@SiO 2 nanocomposite could obviously alleviate MPSinduced destruction in the bone structure ( Figure 6) . A low-attenuation section in the femoral head, referring to the collapse and necrosis situation it was an observed decrease in the Se@SiO 2 plus MPS group compare to the MPS group.
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The histologic analysis of tissues from the heart, liver, spleen, lung, and kidney showed that the structures in those tissues in the Se@SiO 2 +MPS group were comparable to those in the MPS group, suggesting the in vivo safety of Se@SiO 2 ( Figure 6 ).
Discussion
MPS is widely used as an essential drug in the clinical treatment of many diseases including ARDS. Despite the great success, MPS damages the femoral head seriously, which is irreversible. Thus, avoiding the occurrence of ONFH is more important than exploring its effective treatments.
Our study showed that Se@SiO 2 nanocomposites released a beneficial amount of Se slowly. The controlled release and the in vivo stability of Se@SiO 2 nanocomposites contribute to biosafety and low toxicity. 18, [21] [22] [23] In addition, we also examined the main organs and found that the administration 
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Deng et al In diseases that need MPS treatments, such as ARDS, oxidative stress is thought of as the initiating and the main mechanism. 24 SOD and GSH are the principal endogenous antioxidants, which effectively remove the superoxide anion, reduce the oxidative response, and inhibit subsequent acute inflammatory response. 25, 26 Our study showed that Se@SiO 2 has the same therapeutic effects in LPS-induced ARDS model as in paraquat-induced ARDS. Se@SiO 2 nanocomposites induced the production of SOD and GSH-PX, compared with the control group. The levels of SOD and GSH-PX in the MPS+Se@SiO 2 group were similar to those in the MPS group. In addition, the proinflammatory cytokines TNF-α and IL-1β in injured lung tissues were reduced by MPS. The addition of Se@SiO 2 did not affect the inhibitory effect of MPS on both TNF-α and IL-1β levels. The wet-to-dry weight ratio of the lung tissues was reduced after porous Se@SiO 2 or MPS treatment. Se@SiO 2 did not impair the beneficial effect of MPS. The histologic images of rat lung tissues showed that Se@SiO 2 or MPS treatment alleviated the lung tissue damage caused by LPS, whereas the combination of Se@SiO 2 and MPS further protected the lung tissues from damage. Thus, Se@SiO 2 did not impair the therapeutic effect of MPS in the rat models of ARDS. In some aspects, Se@SiO 2 and MPS may achieve a synergistically protective effect.
Previous studies have shown that chronic use of MPS may increase damage by ROS. 27 The induction of ROS may be the fundamental cause of ONFH. Antioxidants have a preventive effect in MPS-induced osteonecrosis in rat models. In our study, we found that Se@SiO 2 nanocomposites promoted the production of the main endogenous antioxidants, including SOD and GSH. Thus, Se@SiO 2 nanocomposites reduced the ROS level indirectly. Our previous studies also suggested that Se@SiO 2 nanocomposites' own antioxidant property could interfere with the disease process of ONFH. 19 Therefore, Se@SiO 2 may have a preventive effect to be used in protection of the femoral head in MPS treatment. Here, we found that Se@SiO 2 nanocomposites, indeed, alleviated MPS-induced destruction in the bone structure. IL-1β is a classical damage index in the cartilage that can be used objectively to evaluate the degree of necrosis. The increase 
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Porous se@siO 2 nanocomposites prevent MPs-induced ONFh of IL-1β promotes inflammation. Our study showed that compared with the control MPS group, Se@SiO 2 significantly reduced the IL-1β level induced by MPS in the cartilage. While collagen type II and aggrecan are both properly constructed and functional proteins in the cartilage, the levels of aggrecan and collagen type II were reduced in the femoral head after MPS treatment. However, Se@SiO 2 increased collagen II and aggrecan dramatically after MPS treatment. Moreover, the protective effect of Se@SiO 2 in MPS-induced ONFH was further confirmed intuitively by a Micro-CT scan and histologic test.
Conclusion
Our study showed that Se@SiO 2 nanocomposites exhibited a protective effect in MPS-induced ONFH without impairing the therapeutic activity of MPS. These results suggest that Se@SiO 2 nanocomposites have potential as effective drugs to minimize ONFH in MPS therapy.
